Literature DB >> 12666180

Quantitative characterization of specific genomic promoters using agarose gel electrophoresis.

Philippe T Georgel1, Jeffrey C Hansen.   

Abstract

Over the past decade a large number of studies have focused attention on the role of nucleosomes as negative and positive regulators of specific nuclear functions. Due to the lack of an analytical method to determine the higher order conformation of the nucleosomal arrays that encompass specific genetic loci (e.g., promoters, enhancers), research emphasis has mostly been centered on chromatin remodeling and histone posttranslational modifications. We have recently developed an agarose gel electrophoresis method that permits us to analyze the higher order structure of specific in vivo assembled chromatin fragments. After calibration using a well-defined in vitro system, we have been able to experimentally determine the size, shape, and conformational flexibility of the Mouse Mammary Tumor Virus long-terminal repeat promoter region in its repressed and activated states. These studies pave the way for widespread analyses of the higher order structure of specific, functionally important chromosomal loci, and in so doing enhance our understanding of the roles that the higher order structure of chromatin play in genome regulations. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666180     DOI: 10.1002/bip.10322

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  2 in total

1.  Chromatin stability at low concentration depends on histone octamer saturation levels.

Authors:  Thomas A Hagerman; Qiang Fu; Benoit Molinié; James Denvir; Stuart Lindsay; Philippe T Georgel
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

2.  Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters.

Authors:  Philippe T Georgel; Terace M Fletcher; Gordon L Hager; Jeffrey C Hansen
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.